
MBRX
Healthcare · Biotechnology · $8.0M market cap
$7.87-0.19 (-2.4%)Nov 13, 4:00 PM EST
Latest report
Time not confirmed
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Dec 31, 2026
EPS trend, 90 days to now · -64.1% over 90 days · 30-day revisions 1 up, 0 down
Beat estimates in 2 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Nov 12, 2026 | Time not confirmed | -8.87 | -9.59 | -8.2% |
| Aug 13, 2026 | After the close | -1.55 | -1.40 | +9.7% |
| May 14, 2026 | After the close | -1.66 | -3.54 | -113.3% |
| Mar 19, 2026 | Time not confirmed | -122.27 | 4.83 | +103.9% |
| Nov 13, 2025 | After the close | -6.58 | -0.68 | +89.7% |
| Aug 12, 2025 | After the close | -10.08 | -12.25 | -21.5% |
| May 13, 2025 | After the close | -13.87 | -17.25 | -24.4% |
| Mar 20, 2025 | After the close | -1.28 | -0.56 | +56.6% |
| Nov 8, 2024 | After the close | -61.00 | -71.25 | -16.8% |
| Aug 13, 2024 | After the close | -62.75 | -42.50 | +32.3% |
| May 10, 2024 | After the close | -88.25 | -50.50 | +42.8% |
| Mar 22, 2024 | After the close | -3.05 | -5.02 | -64.6% |
| Nov 13, 2023 | Before the open | -75.00 |
Moleculin Biotech, Inc., a late-stage pharmaceutical development company, engages in the development of therapeutic candidates for the treatment of tumors and viruses. Its lead drug candidate is Annamycin, an anthracycline, which is in clinical stage for the treatment of relapsed or refractory acute myeloid leukemia and soft tissue sarcoma lung metastases. The company is also developing WP1066 portfolio, including…
| -71.25 |
| +5.0% |
| Aug 10, 2023 | After the close | -99.37 | -75.94 | +23.6% |
| May 10, 2023 | After the close | -114.37 | -103.76 | +9.3% |
| Mar 22, 2023 | After the close | -0.30 | -0.23 | +23.3% |
| Nov 10, 2022 | After the close | -103.75 | -112.50 | -8.4% |
| Aug 12, 2022 | After the close | -95.62 | -96.82 | -1.3% |
| May 11, 2022 | After the close | -78.75 | -90.00 | -14.3% |
| Mar 24, 2022 | After the close | -0.21 | -0.09 | +57.1% |
| Nov 10, 2021 | After the close | -77.50 | -79.50 | -2.6% |
| Aug 11, 2021 | After the close | -70.00 | -71.40 | -2.0% |
| May 12, 2021 | Before the open | -86.25 | -75.00 | +13.0% |
| Mar 24, 2021 | Before the open | -0.58 | -0.26 | +55.2% |
| Nov 12, 2020 | After the close | -210.00 | -224.66 | -7.0% |
| Aug 12, 2020 | Before the open | -202.50 | -189.63 | +6.4% |
| May 11, 2020 | After the close | -225.00 | -227.70 | -1.2% |
| Mar 19, 2020 | After the close | -0.66 | -0.48 | +27.3% |
| Nov 12, 2019 | Before the open | -195.00 | -211.05 | -8.2% |
| Aug 16, 2019 | After the close | -270.00 | -192.60 | +28.7% |
| May 13, 2019 | After the close | -202.50 | -315.00 | -55.6% |
| Feb 21, 2019 | After the close | -225.00 | -225.00 | 0.0% |
| Nov 13, 2018 | Before the open | -292.50 | -180.00 | +38.5% |
| Aug 10, 2018 | After the close | -315.00 | -450.00 | -42.9% |
| May 14, 2018 | After the close | -315.00 | -254.25 | +19.3% |
| Mar 28, 2018 | Before the open | -0.72 | -0.96 | -33.3% |